Skip to main content

Polymer Microspheres for Vaccine Delivery

  • Chapter

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 6))

Abstract

Every year millions of people, particularly children, die of diseases for which a vaccine exists (Walsh, 1988; Warren, 1989). Countless others are left blinded, mentally retarded, or severely crippled. The problem is most significant in developing countries where access to health care is poor. In these countries, it is estimated that more than half of the children who receive primary vaccinations do not complete their required booster immunization schedule (Aguado, 1993; Bloom, 1989). These children are left unprotected, accounting for the enormous number of reported deaths.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ada, G., 1991, Strategies for exploiting the immune system in the design of vaccines, Mol. Immunol. 28(3):225–230.

    Article  PubMed  CAS  Google Scholar 

  • Aguado, M. T., 1993, Future approaches to vaccine development: Single-dose vaccines using controlledrelease delivery systems, Vaccine 11(5):596–597.

    Article  PubMed  CAS  Google Scholar 

  • Aguado, M. T., and Lambert, P.-H., 1992, Controlled-release vaccines — Biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles, Immunobiology 184:113–125.

    Article  PubMed  CAS  Google Scholar 

  • Allcock, H. R., and Kwon, S., 1989, An ionically cross-linkable polyphosphazene: Poly[bis(carboxylatophenoxy)phosphazene] and its hydrogels and membranes, Macromolecules 22:75–79.

    Article  CAS  Google Scholar 

  • Alonso, M. J., Cohen, S., Park, T. G., Gupta, R. K., Siber, G. R., and Langer, R., 1993, Determinants of release rate of tetanus vaccine from polyester microspheres, Pharm. Res. 10(7):945–953.

    Article  PubMed  CAS  Google Scholar 

  • Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., and Langer, R., 1994, Biodegradable microspheres as controlled release tetanus toxoid delivery systems, Vaccine 12(4):299–306.

    Article  PubMed  CAS  Google Scholar 

  • Andrianov, A. K., Payne, L. G., Visscher, K. B., Allcock, H. R., and Langer, R., Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres, J. Appl. Polym. Sci. 53:1573-1578.

    Google Scholar 

  • Arakawa, T., Prestrelski, S. J., Kenney, W. C., and Carpenter, J. F., 1993, Factors affecting short-term and long-term stabilities of proteins, Adv. Drug Deliv. Rev. 10:1–28.

    Article  CAS  Google Scholar 

  • Bloom, B. R., 1989, Vaccines for the third world, Nature 342:115–120.

    Article  PubMed  CAS  Google Scholar 

  • Bomford, R., Stapleton, M., and Winsor, S., 1991, Immunomodulation by adjuvants, in: Vaccines (G. Gregoriadis, A. C. Allison, and G. Poste, eds.), Plenum Press, New York, pp. 25–32.

    Chapter  Google Scholar 

  • Carr, I., 1973, The Macrophage: A Review of Ultrastructure and function, Academic Press, New York.

    Google Scholar 

  • Cohen, S., Baño, M. C., Visscher, K. B., Chow, M., Allcock, H. R., and Langer, R., 1990, Ionically cross-linkable polyphosphazene: A novel polymer for microencapsulation, J. Am. Chem. Soc. 112:7832–7833.

    Article  CAS  Google Scholar 

  • Cohen, S., Bernstein, H., Hewes, C., Chow, M., and Langer, R., 1991a, The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes, Proc. Natl. Acad. Sci. USA 88:10440–10444.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., and Langer, R., 1991b, Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres, Pharm. Res. 8(6):713–720.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, S., Cochrane, A., Nardin, E., and Langer, R., 1992, Poly(lactic/glycolic acid) microspheres — Immunization vehicles for synthetic peptide vaccines, Polym. Mater. Sci. Eng. 66:91–92.

    CAS  Google Scholar 

  • Cohen, S., Alonso, M. J., and Langer, R., 1994, Novel approaches to controlled release antigen delivery, in: Int. J. Tech. Assess. Health Care (A. Robbins and P. Freeman, eds.), Cambridge University Press, London, pp. 121–130.

    Google Scholar 

  • Donbrow, M., 1992, Developments in phase separation methods, aggregation control, and mechanisms of microencapsulation, in: Microcapsules and Nanoparticles in Medicine and Pharmacy (M. Donbrow, ed.), CRC Press, Boca Raton, pp. 17–45.

    Google Scholar 

  • Edelman, R., 1980, Vaccine adjuvants, Rev. Infect. Dis. 2(3):370–383.

    Article  PubMed  CAS  Google Scholar 

  • Edelman, R., Russell, R. G., Losonsky, G., Tall, B. D., Tacket, C. O., Levine, M. M., and Lewis, D. H., 1993, Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly(lactide-co-glycolide), Vaccine 11(2): 155–158.

    Article  PubMed  CAS  Google Scholar 

  • Eldridge, J. H., Meulbroek, J. A., Staas, J. K., Tice, T. R., and Gilley, R.M., 1989, Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response, Adv. Exp. Med. Biol. 251:192–202.

    Google Scholar 

  • Eldridge, J. H., Hammond, C. J., and Meulbroek, J. A., 1990, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer’s patches, J. Control. Rel. 11:205–214.

    Article  CAS  Google Scholar 

  • Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R., and Gilley, R. M., 1991a, Biodegradable microspheres as a vaccine delivery system, Mol. Immunol. 28(3):287–294.

    Article  PubMed  CAS  Google Scholar 

  • Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., and Gilley, R. M., 1991b, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies, Infect. Immun. 59:2978–2986.

    PubMed  CAS  Google Scholar 

  • Eppstein, D. A., Marsh, Y. V., van der Pas, M. A., Feigner, P. L., and Schreiber, A. B., 1985, Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor, Proc. Natl. Acad. Sci. USA 82:3688–3692.

    Article  PubMed  CAS  Google Scholar 

  • Evans, R., and Alexander, P., 1972, Mechanism of immunologically specific killing of tumor cells by macrophages, Nature 236:168–170.

    Article  PubMed  CAS  Google Scholar 

  • Fidler, I. J., Darnell, J. H., and Budmen, M. B., 1976, Tumoricidal properties of mouse macrophages activated with mediators from rat lymphocytes stimulated with concanavalin A, Cancer Res. 36:3608–3615.

    PubMed  CAS  Google Scholar 

  • Fong, J. W., 1979, Processes for preparation of microspheres, U.S. Patent 4,166,800.

    Google Scholar 

  • Freund, J., 1956, The mode of action of immunological adjuvants, Adv. Tuberc. Res. 7:130–148.

    Google Scholar 

  • Gander, B., Thomasin, C., Merkle, H. P., Men, Y., and Corradin, G., 1993, Pulsed tetanus toxoid release from PLGA-microspheres and its relevance for immunogenicity in mice, in: Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Washington, DC, pp. 65–66.

    Google Scholar 

  • Gibbons, A., 1992, A booster shot for children’s vaccines, Science 255:1351.

    Article  PubMed  CAS  Google Scholar 

  • Gilding, D. K., and Reed, A. M., 1979, Biodegradable polymers for use in surgery: Polyglycolic/poly(lactic acid) homo-and copolymers: 1, Polymer 20:1459–1464.

    Article  CAS  Google Scholar 

  • Gilley, R. M., Staas, J. K., Tice, T. R., Morgan, J. D., and Eldridge, J. H., 1992, Microencapsulation and its application to vaccine development, in: Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Orlando, pp. 110–111.

    Google Scholar 

  • Glenny, A. T., Buttle, G. A. H., and Stevens, M. F., 1931, Rate of disappearance of diphtheria toxoid injected into rabbits and guinea-pigs: Toxoid precipitated with alum, J. Pathol. Bacteriol. 34:267–275.

    Article  CAS  Google Scholar 

  • Gupta, R. K., Siber, G. R., Alonso, M. J., and Langer, R., 1993, Development of a single dose tetanus toxoid based on controlled release from biodegradable and biocompatible polyester microspheres, in: Vaccines 93 (F. Brown, R. Chenock, H. Ginsberg, and R. Lerner, eds.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 391–396.

    Google Scholar 

  • Hanes, J., and Langer, R., 1995, Polymeric controlled release vaccine delivery systems, in: Reproductive Immunology (R. Bronson, N. Alexander, D. Anderson, D. W. Branch, and W. H. Kutteh, eds.), Blackwell, Oxford (in press).

    Google Scholar 

  • Hibbs, J. B. Jr., Taintor, R. R., Chapman, H. A. Jr., and Weinberg, J. B., 1977, Macrophage tumor killing: Influence of the local environment, Science 197:279–282.

    Article  PubMed  Google Scholar 

  • Kibat, P. G., Igari, Y., Wheatley, M. A., Eisen, H. N., and Langer, R., 1990, Enzymatically activated microencapsulated liposomes can provide pulsatile drug release, FASEB J. 4:2533–2539.

    PubMed  CAS  Google Scholar 

  • Kohn, J., and Langer, R., 1986, Poly(iminocarbonates) as potential biomaterials, Biomaterials 7:176–182.

    Article  PubMed  CAS  Google Scholar 

  • Kohn, J., and Langer, R., 1987, Polymerization reactions involving the side chains of alpha-L-amino acids, J. Am. Chem. Soc. 109:817–820.

    Article  CAS  Google Scholar 

  • Kohn, J., Niemi, S. M., Albert, E. C., Murphy, J. C., Langer, R., and Fox, J. G., 1986, Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity, J. Immunol. Methods 95:31–38.

    Article  PubMed  CAS  Google Scholar 

  • Kost, J., and Langer, R., 1992, Responsive polymer systems for controlled delivery of therapeutics, Trends Biotechnol. 10(4):127–131.

    Article  PubMed  CAS  Google Scholar 

  • Kraehenbuhl, J.-P., and Neutra, M. R., 1992, Transepithelial transport and mucosal defence II: Secretion of IgA, Trends Cell Biol. 2:170–174.

    Article  PubMed  CAS  Google Scholar 

  • Langer, R., 1981, Polymers for the sustained release of macromolecules: Their use in a single-step method of immunization, Methods Enzymol. 73:57–75.

    Article  PubMed  CAS  Google Scholar 

  • Langer, R., 1990, New methods of drug delivery, Science 249:1527–1533.

    Article  PubMed  CAS  Google Scholar 

  • Lewis, D. H., 1990, Controlled release of bioactive agents from lactide/glycolide polymers, in: Biodegradable Polymers as Drug Delivery Systems (M. Chasin and R. Langer, eds.), Dekker, New York, pp. 1–41.

    Google Scholar 

  • Liu, R., Langer, R., and Klibanov, A. M., 1991, Moisture-induced aggregation of lyophilized proteins in the solid state, Biotechnol. Bioeng. 37:177–184.

    Article  PubMed  CAS  Google Scholar 

  • McQueen, C. E., Boedeker, E. C., Reid, R., Jarboe, D., Wolf, M., Le, M., and Brown, W. R., 1993, Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1, Vaccine 11(2): 201–206.

    Article  PubMed  CAS  Google Scholar 

  • Mitchison, N.A., 1990, Gonadotrophin vaccines, Curr. Opin. Immunol. 2:725–727.

    Article  CAS  Google Scholar 

  • Moldoveanu, Z., Staas, J. K., Gilley, R. M., Ray, R., Compans, R. W., Eldridge, J. H., Tice, T. R., and Mestecky, J., 1989, Immune responses to influenza virus in orally and systemically immunized mice, Curr. Top. Microbiol. Immunol. 146:91–99.

    Article  PubMed  CAS  Google Scholar 

  • Moldoveanu, Z., Novak, M., Huang, W. Q., Gilley, R. M., Staas, J. K., Schafer, D., Compans, R. W., and Mestecky, J., 1993, Oral immunization with influenza virus in biodegradable microspheres, J. Infect. Dis. 167(1):84–90.

    Article  PubMed  CAS  Google Scholar 

  • Neutra, M. R., and Kraehenbuhl, J.-P., 1992, Transepithelial transport and mucosal defence I: The role of M cells, Trends Cell Biol. 2:134–138.

    Article  PubMed  CAS  Google Scholar 

  • O’Hagan, D. T., 1990, Intestinal translocation of particulates — Implications for drug and antigen delivery, Adv. Drug Deliv. Rev. 5:265–285.

    Article  Google Scholar 

  • O’Hagan, D. T., Jeffery, H., and Davis, S. S., 1993a, Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles, Vaccine 11(9):965–969.

    Article  PubMed  Google Scholar 

  • O’Hagan, D. T., McGee, J. P., Holmgren, J., Mowat, A. M., Donachie, A. M., Mills, K. H. G., Gaisford, W., Rahman, D., and Challacombe, S. J., 1993b, Biodegradable microparticles for oral immunization, Vaccine 11:149–154.

    Article  PubMed  Google Scholar 

  • Okada, H., Inoue, Y., Heya, T., Ueno, H., Ogawa, Y., and Toguchi, H., 1991, Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate, Pharm. Res. 8:787–791.

    Article  PubMed  CAS  Google Scholar 

  • Payne, L. G., Jenkins, S. A., Andrianov, A., Langer, R., and Roberts, B. E., 1995, Xenobiotic polymers as vaccine vehicles, in: Advances in Experimental Medicine and Biology (J. R. McGee and J. Mestecky, eds.), Plenum Press, New York (in press).

    Google Scholar 

  • Preis, I., and Langer, R., 1979, A single-step immunization by sustained antigen release, J. Immunol. Methods. 28:193–197.

    Article  PubMed  CAS  Google Scholar 

  • Reid, R. H., Boedeker, E. C., McQueen, C. E., Davis, D., Tseng, L.-Y, Kodak, J., Sau, K., Wilhelmsen, C. L., Nellore, R., Dalai, P., and Bhagat, H. R., 1993, Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli, Vaccine 11(2): 159–167.

    Article  PubMed  CAS  Google Scholar 

  • Santiago, N., Milstein, S. J., Rivera, T., Garcia, E., Chang, T. C., Baughman, R. A., and Bucher, D., 1992, Oral immunization of rats with influenza virus M protein (Ml) microspheres, in: Proc. Int. Symp. Control Rel Bioact. Mater., Controlled Release Society, Orlando, pp. 116–117.

    Google Scholar 

  • Schneider, A. K., 1972, Polylactide sutures, U.S. Patent 3,636,956.

    Google Scholar 

  • Schreier, H., Levy, M., and Milhalko, P., 1987, Sustained release of liposome-encapsulated gentamicin and fate of phospholipid following intramuscular injection in mice, J. Control. Rel. 5:187–192.

    Article  CAS  Google Scholar 

  • Staas, J. K., Hunt, R. E., Marx, P. A., Compans, R. W., Smith, J. F., Eldridge, J. H., Gibson, J. W., Tice, T. R., and Gilley, R. M., 1993, Mucosal immunization using microsphere delivery systems, in: Proc. Int. Symp. Control Rel. Bioact. Mater., Controlled Release Society, Washington, DC, pp. 63–64.

    Google Scholar 

  • Stevens, V. C., 1993, Vaccine deblivery systems: Potential methods for use in antifertility vaccines, Am. J. Reprod. Immunol. 29:176–188.

    PubMed  CAS  Google Scholar 

  • Stevens, V. C., Powell, J. E., Lee, A. E., Kaumaya, P. T. P., Lewis, D. H., Rickey, M., and Atkins, T. J., 1992, Development of a delivery system for a birth control vaccine using biodegradable microspheres, in: Proc. Int. Symp. Control Rel. Bioact. Mater., Controlled Release Society, Orlando, pp. 112–113.

    Google Scholar 

  • Tabata, Y., and Ikada, Y., 1986, Phagocytosis of bioactive microspheres, J. Bioact. Compat. Polym. 1:32–46.

    Article  Google Scholar 

  • Tabata, Y., and Ikada, Y., 1987, Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres, J. Pharm. Pharmacol. 39:698–704.

    Article  PubMed  CAS  Google Scholar 

  • Tabata, Y., and Ikada, Y., 1988a, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage, Biomaterials 9(4):356–362.

    Article  PubMed  CAS  Google Scholar 

  • Tabata, Y., and Ikada, Y., 1988b, Macrophage phagocytosis of biodegradable microspheres composed of L-lactic/glycolic acid homo-and copolymers, J. Biomed. Mater. Res. 22:837–858.

    Article  PubMed  CAS  Google Scholar 

  • Tabata, Y., and Ikada, Y., 1989a, Protein precoating of polylactide microspheres containing a lipophibc immunopotentiator for enhancement of macrophage phagocytosis and activation, Pharm. Res. 6(4):296–301.

    Article  PubMed  CAS  Google Scholar 

  • Tabata, Y., and Ikada, Y., 1989b, Synthesis of gelatin microspheres containing interferon, Pharm. Res. 6(5):422–427.

    Article  PubMed  CAS  Google Scholar 

  • Tabata, Y., and Ikada, Y., 1990, Drug debvery systems for antitumor activation of macrophages, Crit. Rev. Then Drug Carrier Syst. 7(2): 121–148.

    CAS  Google Scholar 

  • Tabata, Y., Nakaoka, R., and Ikada, Y., 1993, Potentiality of gelatin microspheres as an immunological adjuvant, in: Proc. Int. Symp. Control. Rel. Bioact. Mater., Controlled Release Society, Washington, DC, pp. 392–393.

    Google Scholar 

  • Talwar, G. P., and Raghupathy, R., 1989, Anti-fertibty vaccines, Vaccine 7:97–101.

    Article  PubMed  CAS  Google Scholar 

  • Tice, T. R., and Tabibi, S. E., 1992, Parenteral drug delivery: Injectables, in: Treatise on Controlled Drug Delivery (A. Kydonieus, ed.), Dekker, New York, pp. 315–339.

    Google Scholar 

  • Volkin, D. B., and Klibanov, A. M., 1989, Minimizing protein inactivation, in: Protein Function: A Practical Approach (T. E. Creighton, ed.), IRL Press, Oxford, pp. 1–24.

    Google Scholar 

  • Walsh, J. A., 1988, Establishing health priorities in the developing world, United Nations Development Programme, Report.

    Google Scholar 

  • Warren, K. S., 1989, The biotechnology and children’s revolutions, in: Immunization (R. K. Root, K. S. Warren, J. Griffiss, and M. A. Sande, eds.), Churchill Livingstone, Edinburgh, pp. 1–9.

    Google Scholar 

  • Weiner, A. L., Carpenter-Green, S. S., Soehngen, E. C., Lenk, R. P., and Popescu, M. C., 1985, Liposomecollagen gel matrix: A novel sustained drug delivery system, J. Pharm. Sci. 74(9):922–925.

    Article  PubMed  CAS  Google Scholar 

  • Wheeler, A. W., Moran, D. M., Robins, B. E., and Driscoll, A., 1982, L-Tyrosine as an immunological adjuvant, Int. Arch. Allergy Appl. Immun. 69:113–119.

    Article  CAS  Google Scholar 

  • Wheeler, A. W., Whittall, N., Spackman, V., and Moran, D. M., 1984, Adjuvant properties of hydrophobic derivatives prepared from L-tyrosine, Int. Arch. Allergy Appl. Immunol. 75:294–299.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hanes, J., Chiba, M., Langer, R. (1995). Polymer Microspheres for Vaccine Delivery. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1823-5_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5737-7

  • Online ISBN: 978-1-4615-1823-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics